Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets.
about
Staphylococcal superantigens in colonization and diseaseDistinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureusModulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7Characterization of an Actin-targeting ADP-ribosyltransferase from Aeromonas hydrophilaHighly selective end-tagged antimicrobial peptides derived from PRELPNovel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumoniaStaphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tacticStaphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?Powerful genetic resource for the study of methicillin-resistant Staphylococcus aureus.Structural model of the pre-pore ring-like structure of Panton-Valentine leukocidin: providing dimensionality to biophysical and mutational data.The pleiotropic CymR regulator of Staphylococcus aureus plays an important role in virulence and stress responseModulation of paired immunoglobulin-like type 2 receptor signaling alters the host response to Staphylococcus aureus-induced pneumoniaStaphylococcus epidermidis strategies to avoid killing by human neutrophilsStaphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia.Neutrophil bleaching of GFP-expressing staphylococci: probing the intraphagosomal fate of individual bacteria.Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathwaysChemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract.Multiple length peptide-pheromone variants produced by Streptococcus pyogenes directly bind Rgg proteins to confer transcriptional regulation.PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps.Human transferrin confers serum resistance against Bacillus anthracisCysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins.Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivoPlatelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates, from which bacteria subsequently escape.The pore-forming toxin β hemolysin/cytolysin triggers p38 MAPK-dependent IL-10 production in macrophages and inhibits innate immunity.Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus.Genetic tools to enhance the study of gene function and regulation in Staphylococcus aureusA genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genesDextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group a streptococcal sepsis.Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.Identification of the Staphylococcus aureus vfrAB operon, a novel virulence factor regulatory locusIgniting the fire: Staphylococcus aureus virulence factors in the pathogenesis of sepsis.Identification of the amino acids essential for LytSR-mediated signal transduction in Staphylococcus aureus and their roles in biofilm-specific gene expression.Bacterial glycosidases in pathogenesis and glycoengineering.Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner.Identification of Quorum-Sensing Inhibitors Disrupting Signaling between Rgg and Short Hydrophobic Peptides in Streptococci.Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and VirulenceAntibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin PairsSerine/threonine phosphatase (SP-STP), secreted from Streptococcus pyogenes, is a pro-apoptotic protein.Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis.
P2860
Q26995577-27A87818-85AF-477F-B0AE-ED4C52BDA253Q27313965-C9BC4551-1662-457D-B0C0-887CC13C9913Q27317705-7AC83A36-BF6B-4524-BFFA-7D082EFFA6A9Q27672924-B5A06120-A4D5-4EA2-B3F9-2DCA483F64C2Q28476835-5A2EF0A1-6BBE-47E3-88B3-FAAA32B0BAD3Q28728777-FC381673-70DC-4CF9-AFFF-3EECD202E234Q28729029-7DA2E998-74BC-4E62-A74F-6B47C910DDE0Q30239977-2C953D5D-CA89-4998-AD16-0882B4D3C746Q31114329-ED632A43-5850-4AF2-8348-E7F2C232BB17Q33579346-A27E1674-F7D0-4214-A5B3-613FB88E1EA4Q33582244-753E7177-BE70-4B28-8315-9052D0B68B68Q33675732-02384FF6-C1F1-4263-A6B1-08C80868E363Q33719408-66808416-82D4-4A2F-9E87-BDFA42F25032Q33769082-43839922-7D99-411D-9860-318D3ABDFF9FQ33895971-41B54344-AC0E-42C7-AD3D-295E6F7FBBE1Q33963770-B0DE932F-5286-4149-B46B-D54117782D8BQ33996850-D13E7E8A-918E-4BF8-AC58-CB8255B3ED1AQ34070474-7AF4DDDF-7CF8-4372-8EE9-33E7512A7537Q34096547-AFD18185-5D0D-4A21-92DE-94D3B327BB10Q34107185-E4BCCA00-B82B-4C13-A5D2-D336C6626CFAQ34229809-33B9035C-6334-4722-908F-BB5B117C1BF1Q34298337-55CCBB5C-FB09-4B0D-980B-0836E26FBF8DQ34298556-5239A925-7B48-49F8-8012-1CA53026C9D7Q34350899-EDDFDF32-F31E-4F3B-ACBC-CA1185055B09Q34463131-EF6D15E6-80C2-455A-8C89-E0C14C2958F8Q34564815-55B0B2FB-8FAC-4E99-85BC-F1BE2F00B92EQ34583671-85A36275-9537-48C6-AB78-A7F67F959A67Q34737209-FFA178FF-1F31-4A2F-89A8-EA1B7130B442Q34769869-25ABDEA0-200F-4CA3-BDF3-1127539DB5E7Q35096919-A787D8B6-F9B6-4E8A-8D89-E6A295F1D1A4Q35097096-834FCE41-B451-4BB1-AB2A-62868C07B7F1Q35140792-5CF31EFE-7115-4A6F-AE7E-4E367B715B1AQ35362348-400D78F9-74DE-4648-A1D5-FA6053E7D0FEQ35552227-7A4057D2-0B9C-4273-A16A-148176FC42C0Q35620197-1D5C4C08-D459-40A2-83AA-9C29D4D0B633Q35673338-F33FD998-957D-4012-86E0-5B26167FF382Q35754856-0CD35CA2-63BB-4E8C-9CB0-FA222D8E8817Q35772579-EFF54326-87A2-430E-AD34-2F5F7A29A725Q35841887-29A58CF2-335F-4068-BCB4-73F4A16E226BQ35851869-224E6837-9591-40FC-845D-A0C4CE903A98
P2860
Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Understanding how leading bact ...... eal novel therapeutic targets.
@en
type
label
Understanding how leading bact ...... eal novel therapeutic targets.
@en
prefLabel
Understanding how leading bact ...... eal novel therapeutic targets.
@en
P1476
Understanding how leading bact ...... eal novel therapeutic targets.
@en
P356
10.1016/J.JACI.2007.06.005
P407
P50
P577
2007-07-01T00:00:00Z